2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $6.1B | $7.5B | $8.2B | $7.4B | $8.2B |
Cost of Revenue | $5.1B | $6B | $6.1B | $5.6B | $6.2B |
Gross Profit | $1B | $1.5B | $2.1B | $1.8B | $2B |
Gross Profit % | 17% | 21% | 25% | 24% | 24% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $250M | $682M | $1.1B | $769M | $887M |
Dep. & Amort. | $37M | $40M | $34M | $33M | $41M |
Def. Tax | $51M | $87M | $84M | -$169K | -$8.4M |
Stock Comp. | $32M | $20M | $27M | $26M | $22M |
Chg. in WC | $714M | -$496M | -$180M | -$49M | -$848M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $533M | $833M | $724M | $799M | $487M |
ST Investments | $5.3M | $2.1M | $1.1M | $0 | $0 |
Cash & ST Inv. | $538M | $835M | $726M | $799M | $487M |
Receivables | $96M | $151M | $192M | $185M | $218M |
Inventory | $5.3B | $5.5B | $5.4B | $5.5B | $6.2B |
TMHC delivered 3,048 homes in Q1 at an average price of $600,000, generating $1.8 billion in home closings revenue (up 12% YoY), with an adjusted home closings gross margin of 24.8% (up 80 bps YoY) and adjusted EPS up 25% YoY; book value per share grew 16% to ~$58.
For 2024, TMHC now expects to deliver 13,000–13,500 homes (down from prior guidance of 13,500–14,000), with a home closings gross margin around 23% (low end of prior guidance), and average closing price for the year between $590,000–$600,000; Q2 guidance is for ~3,200 deliveries at a 23% gross margin and ~$585,000 average price.
Spec home closings rose to 58% in Q1 (record 27% sold and closed in the quarter), with spec penetration expected to remain high (~60%) in Q2, leading to higher incentives and lower margins; finished inventory at quarter end was elevated at 2.4 homes per community.
Land investment for 2024 is reduced to $2.4–$2.6 billion (from ~$2.6 billion prior), with a focus on more favorable option structures and disciplined underwriting; owned and controlled lot inventory stands at 86,266 lots (6.5 years supply), with 59% controlled via options/off-balance sheet.
April sales pace has been choppy due to macro volatility, with consumer hesitation driven by affordability concerns and economic uncertainty; cancellations ticked up slightly post-quarter but are expected to normalize; TMHC remains confident in its long-term goal of 20,000 closings by 2028, prioritizing returns and balance sheet health over growth for growth’s sake.